A radiomic biomarker for prognosis of resected colorectal cancer liver metastases generalizes across MRI contrast agents

A radiomic biomarker for prognosis of resected colorectal cancer liver metastases generalizes across MRI contrast agents

IntroductionContrast-enhanced MRI is routinely performed as part of preoperative work-up for patients with Colorectal Cancer Liver Metastases (CRLM). Radiomic biomarkers depicting the characteristics of CRLMs in MRI have been associated with overall survival (OS) of patients, but the reproducibility...

Full description

Bibliographic Details
Main Authors: Jianan Chen, Helen M. C. Cheung, Paul J. Karanicolas, Natalie G. Coburn, Guillaume Martel, Albert Lee, Chirag Patel, Laurent Milot, Anne L. Martel
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
colorectal cancer
liver
metastasis
MRI
radiomics
contrast agents
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.898854/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.898854/full

Similar Items